Many views on aging based on misconceptions, survey finds
By
Alicia Lasek
Oct 29, 2019
The care of older adults is mired in misinformation, according to a new survey by WebMD and The John A. Hartford Foundation.
Most seniors with dementia willing to reduce unnecessary meds: survey
By
Alicia Lasek
Mar 11, 2022
Fully 87% of seniors with probable or possible dementia say they would be willing to stop at least one medication if their doctor gave them the go-ahead.
Survey: Short-stay residents want more help with meds, clinician connections upon discharge
By
Alicia Lasek
Nov 03, 2021
Fully 80% of respondents said they received and understood their discharge instructions. But at least two-thirds would have liked more help with their medication regimen, physician referrals, and other...
With education and a doc’s OK, most seniors agree to deprescribe unneeded meds: study
By
Alicia Lasek
Jan 10, 2023
Seniors are willing to take their doctor’s advice to discontinue an unneeded medication after viewing an educational video, investigators say.
Many seniors ready to shrink their lists of prescription drugs, survey reveals
By
Alicia Lasek (f3)
Jun 07, 2022
Many older adults say they are motivated to cut down on their prescription medications to avoid future side effects — if their physician suggests they do so.
Pharmacists poised to continue transition into direct care roles, survey finds
By
Alicia Lasek
Jan 25, 2022
Pharmacists will continue to move into central roles in healthcare, including chronic disease management in the adult patient population, the authors say.
Muscle relaxant prescriptions have tripled for older adults, investigators find
By
Alicia Lasek
Jun 30, 2020
Clinicians may be prescribing the drugs as an opioid alternative for chronic pain management, propose the researchers. Opioids are often prescribed simultaneously, they found.
Study: LTC residents with COVID-19 at risk for polypharmacy, new drug interactions
By
Alicia Lasek
Apr 12, 2022
Across 41 Texas long-term care facilities, nearly 20% of residents with COVID-19 had drug-drug interactions related to treatment, and one-third continued new meds 30 days after diagnosis.
Adding rasagiline to treatment regimen may help those with Parkinson’s, study finds
By
Kristen Fischer
Oct 16, 2023
A recent study finds that the addition of rasagiline (marketed as Azilect) to the treatment regimen of individuals with Parkinson’s disease significantly enhances clinical outcomes.